CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.2.2.1 Competitive intelligence of companies and their strategies
3.3 Porters Five Forces Analysis
3.3.1 Bargaining power of the suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Competitive rivalry
3.3.5 Threat of substitutes
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Increasing demand for minimally invasive reconstruction surgeries
3.4.1.2 Technological advancement
3.4.1.3 Congenital face and tooth deformities
3.4.1.4 Awareness about aesthetics appearance
3.4.2 Restraints
3.4.2.1 High cost of treatment and low reimbursements
3.4.2.2 Risk of malfunctions
3.4.3 Opportunities
3.4.3.1 Preference for a better quality of life
3.4.3.2 Adoption of cosmetic implants to enhance aesthetic looks
CHAPTER 4 WORLD COSMETIC IMPLANTS MARKET, BY PRODUCT
4.1 Market size and forecast
4.2 Dental implants
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Plate-form dental implants
4.2.5 Root-form dental implants
4.3 Breast implants
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Facial implants
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.5 Other implants
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Buttock implants
4.5.4.1 Buttock implants market size and forecast
4.5.5 Calf implants
4.5.5.1 Calf implants market size and forecast
4.5.6 Pectoral implants
4.5.6.1 pectoral implants market size and forecast
4.5.7 Penile implants
4.5.7.1 Penile implants market size and forecast
4.5.8 Ear implants
4.5.8.1 EAr implants market size and forecast
CHAPTER 5 WORLD COSMETIC IMPLANTS MARKET, BY RAW MATERIAL
5.1 Overview
5.1.1 Market size and forecast
5.1.2 Ceramics
5.1.2.1 Market size and forecast
5.1.3 Biomaterials
5.1.3.1 Market size and forecast
5.1.4 Polymers
5.1.4.1 Market size and forecast
5.1.5 Metals
5.1.5.1 Market size and forecast
CHAPTER 6 WORLD COSMETIC IMPLANTS MARKET, BY GEOGRAPHY, 2014-2022
6.1 Overview
6.2 Market size and forecast
6.3 North America
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 U.S. market size and forecast
6.3.5 Canada market size and forecast
6.3.6 Mexico market size and forecast
6.4 Europe
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Germany market size and forecast
6.4.5 France market size and forecast
6.4.6 U.K. market size and forecast
6.4.7 Italy market size and forecast
6.4.8 Spain market size and forecast
6.4.9 Rest of Europe market size and forecast
6.5 Asia-Pacific
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Japan market size and forecast
6.5.5 China market size and forecast
6.5.6 India market size and forecast
6.5.7 South Korea market size and forecast
6.5.8 Australia market size and forecast
6.5.9 Others market size and forecast
6.6 LAMEA
6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast
6.6.4 Brazil market size and forecast
6.6.5 Saudi Arabia market size and forecast
6.6.6 Colombia market size and forecast
6.6.7 Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Allergan plc
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Business Performance
7.1.5 Key Strategic Moves and Developments
7.2 Danaher Corporation
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating Business Segments
7.2.4 Business Performance
7.2.5 Key Strategic Moves and Developments
7.3 Dentsply Sirona Inc. (formerly DENTSPLY International Inc.)
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating Business Segments
7.3.4 Business Performance
7.3.5 Key Strategic Moves and Developments
7.4 GC Aesthetics plc
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating Business Segments
7.4.4 Business Performance
7.4.5 Key Strategic Moves and Developments
7.5 Institut Straumann AG
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments
7.5.4 Business Performance
7.5.5 Key Strategic Moves and Developments
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.6.4 Business Performance
7.6.5 Key Strategic Moves and Developments
7.7 3M Company
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating Business Segments
7.7.4 Business Performance
7.8 Polytech Health & Aesthetics GmbH
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating Business Segments
7.9 Sientra Inc.
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating Business Segments
7.9.4 Business Performance
7.10 Zimmer Biomet Holdings, Inc.
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating Business Segments
7.10.4 Business Performance
7.10.5 Key Strategic Moves and Developments